September 28, 2018 โ At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico ...
William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio ...
September 26, 2018 โ Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
July 26, 2018 โ The pivotal clinical study in the U.S. of the Abbott Tendyne Transcatheter Mitral Valve Replacement ...
July 18, 2018 โ Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next ...
June 1, 2018 โ Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
May 25, 2018 โ Abbott announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne ...
May 25, 2018 โ Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience Sierra ...
May 23, 2018 โ Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a ...
May 11, 2018 โ The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial ...